Illumina Inc (ILMN) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
Over the past 4 years, Illumina Inc has achieved a revenue compound annual growth rate (CAGR) of -0.9%.
Historical revenue and profitability trends for Illumina Inc
The chart above illustrates Illumina Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Illumina Inc's business.
How efficiently Illumina Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Illumina Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Illumina Inc to continue growing earnings in the coming year. The consensus analyst rating is 3.68 based on 25 analysts.
Based on our comprehensive analysis, Illumina Inc (ILMN) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Illumina Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Illumina Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: ILMN Valuation, ILMN Dividend, ILMN Financial Health
Compare: ILMN vs AAPL, ILMN vs MSFT, ILMN vs GOOGL